However, using antibodies against β‐catenin phosphorylation sites at serine 675 and 552, we observed a significant decrease in protein levels at these sites, suggesting that CENPA may promote cancer by affecting the phosphorylation of β‐catenin protein (Figure 9A). Here, CENPA is linked to cancer.